DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Transitions: Linkages From Jail To Community

Not Applicable

Completed

Conditions: HIV Infections
Substance Abuse
HIV

Interventions: Behavioral: Intensive Case Management

First Posted Date: 2009-02-11

Last Posted Date: 2016-08-12

Lead Sponsor: Yale University

Target Recruit Count: 127

Registration Number: NCT00841711

Locations: 🇺🇸
Waterbury Hosp ID Clinic, Waterbury, Connecticut, United States
🇺🇸
Yale Clinical Research, New Haven, Connecticut, United States

Pharmacotherapy & CM for Opioid and Cocaine Dependence

Phase 1

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Sugar Pill
Drug: Modafinil
Behavioral: Contingency Management
Drug: Methadone
Behavioral: cognitive behavioral treatment
Behavioral: Voucher Control

First Posted Date: 2009-02-09

Last Posted Date: 2021-12-03

Lead Sponsor: Yale University

Target Recruit Count: 91

Registration Number: NCT00838981

Locations: 🇺🇸
Department of Veterans Affairs, West Haven, Connecticut, United States

Positive Lifestyles Using Safety

Not Applicable

Completed

Conditions: HIV
HIV Infections

Interventions: Behavioral: Post-release (Group 2)
Behavioral: Pre-Release (Group 1)

First Posted Date: 2009-02-04

Last Posted Date: 2015-10-21

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT00836290

Locations: 🇺🇸
Yale AIDS Program, Yale University School of Medicine, New Haven, Connecticut, United States

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Not Applicable

Completed

Conditions: Binge Eating
Obesity

Interventions: Behavioral: Behavioral Weight Loss
Behavioral: Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy
Drug: Placebo
Drug: Sibutramine/Orlistat

First Posted Date: 2009-01-27

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 191

Registration Number: NCT00829283

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Biological Clock Dysfunction in Optic Nerve Hypoplasia

Early Phase 1

Completed

Conditions: Biological Clock Dysfunction
Optic Nerve Hypoplasia

Interventions: Dietary Supplement: Melatonin
Dietary Supplement: Placebo Comparator

First Posted Date: 2009-01-21

Last Posted Date: 2020-09-25

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00825591

Locations: 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States

Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Non-Small Cell Lung Cancer (NSCLC)

Interventions: Drug: Vorinostat
Radiation: Radiotherapy

First Posted Date: 2009-01-14

Last Posted Date: 2020-11-20

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT00821951

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.

Withdrawn

Conditions: Intraocular Pressure

Interventions: Device: Dynamic contour tonometry

First Posted Date: 2009-01-07

Last Posted Date: 2016-05-13

Lead Sponsor: Yale University

Registration Number: NCT00818233

Locations: 🇺🇸
Yale Eye Center, New Haven, Connecticut, United States

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Not Applicable

Completed

Conditions: HIV Infections
AIDS
Human Immunodeficiency Virus
Acquired Immune Deficiency Syndrome

Interventions: Other: Standard treatment regimen
Drug: Raltegravir
Drug: Atazanavir

First Posted Date: 2008-12-25

Last Posted Date: 2016-02-04

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00814879

Locations: 🇺🇸
Saint Raphael Healthcare System, New Haven, Connecticut, United States
🇺🇸
Waterbury Hospital, Waterbury, Connecticut, United States
🇺🇸
VA CT Healthcare Systems, West Haven, Connecticut, United States

and more 2 locations

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Galantamine
Behavioral: Computer Assisted Cognitive Behavioral Therapy (CBT)

First Posted Date: 2008-12-17

Last Posted Date: 2019-01-30

Lead Sponsor: Yale University

Target Recruit Count: 120

Registration Number: NCT00809835

Locations: 🇺🇸
Regional Network of Programs, Stratford, Connecticut, United States
🇺🇸
Kinsella Treatment Center (KTC), Bridgeport, Connecticut, United States

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Phase 2

Completed

Conditions: Seasonal Affective Disorder

Interventions: Device: Light-emitting Photodiode light treatment device
Device: Negative Ion Generator

First Posted Date: 2008-12-17

Last Posted Date: 2013-03-06

Lead Sponsor: Yale University

Target Recruit Count: 106

Registration Number: NCT00809523

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇨🇦
St. John Regional Hospital, St. John, New Brunswick, Canada
🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy